Past Issues

Past Issues

Articles

Perspectives on the Science

Editorials

Immunotherapy and Cardiovascular Health - A Cause for Concern?

In this Perspectives on the Science piece we reflect on the impact of ‘Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque’ by Drobni et al.
May 1, 2023
Miller, David M., Ferris, Laura K., Gupta, Sameer, Brownell, Isaac, Shalhout, Sophia Z.

Perioperative Immunotherapy for High-Risk Resectable Melanoma - A New Standard?

In this Perspectives on the Science piece we reflect on the impact of the recently published SWOG S1801 trial.
Apr 15, 2023
Serena Vilasi, David Michael Miller MD, PhD, Howard Lane Kaufman MD, Kevin Scott Emerick, Sophia Zaki Shalhout PhD, Emily Y Kim, Vishal Anil Patel MD, Khalid Garmen, Sameer Gupta MD, Isaac Brownel MD, PhD

Skin Cancer Chemoprevention for Transplant Recipients - The Search Continues

In this Perspectives on the Science piece, we reflect on the impact of the recently published ONTRANS trial.
Mar 22, 2023
Howard Lane Kaufman MD, Vishal Anil Patel MD, Sophia Zaki Shalhout PhD, Sameer Gupta MD, Sonia Cohen MD, PhD, Isaac Brownell MD, PhD, David Michael Miller MD, PhD

Lacking Overall IMspiration for Triplet Therapy in Melanoma? A Review of the Interim Analysis of IMspire150.

In this Perspectives on the Science piece, we reflect on the impact of the recently published article by Ascierto et al. in Lancet Oncology that provides interim results from IMspire150.
Feb 4, 2023
David Michael Miller MD, PhD, Kevin Scott Emerick MD, Vishal Anil Patel MD, Sonia Cohen MD, PhD, Isaac Brownell MD, PhD, Donald P. Lawrence MD

Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?

In this Perspectives on the Science piece, we reflect on the impact of the recently published article “Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma”.
Jan 9, 2023
Emily Y Kim, Sophia Zaki Shalhout PhD, Howard Lane Kaufman MD, Kevin Scott Emerick MD, Vishal Anil Patel MD, Khalid Garmen MD, PhD, Isaac Brownell MD, PhD, David Michael Miller MD, PhD

Neoadjuvant Nivo/Rela for Resectable Melanoma

In this Perspectives on the Science piece we reflect on the impact of the recently published article Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Dec 5, 2022
David Michael Miller MD, PhD, Howard Lane Kaufman, Kevin Scott Emerick MD, Justine V. Cohen MD, Emily Y. Kim, Sophia Zaki Shalhout PhD.

Ipi/Nivo for Advanced MCC

In this Perspectives on the Science piece we reflect on the impact of the recently published article “Combined Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy for Advanced Merkel cell carcinoma - A Randomised, Open Label, Phase 2 Trial”.
Nov 21, 2022
Shalhout, Sophia Z., Cohen, Justine V., Garmen, Khalid, Kim, Emily Y., Cohen, Sonia, Miller, David M.

Neoadjuvant ICI for Resectable CSCC

In this Perspectives on the Science piece we reflect on the impact of the recently published article “Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma”.
Nov 8, 2022
Miller, David M., Patel, Vishal A., Cohen, Justine V., Garmen, Khalid, Shalhout, Sophia Z.
No matching items

Cover Art
The cover art for Volume 1 Issue 1 was created by David M. Miller using Open AI’s DALL·E software. The image represents a tumor-infiltrating lymphocyte primed to execute effector functions against a neoplastic cell.